Clinical trial · Observational
Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer
NCT02854982CI-TRIAL-00115399EPICAP-QALYcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To study the quality of life of patients with prostate cancer at a distance from their care at a time when they are supposed to have taken a "normal" life and compared to subjects without cancer prostate of the same age.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostatic Neoplasms | Prostate Neoplasm | ALIAS | 0.90 |
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| therapeutic management of the prostate Cancer as usual | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Prostate Cancer
- description
- Group drawn of the case group of the case control study, entitled EPICAP
- interventionNames
- Procedure: therapeutic management of the prostate Cancer as usual
- label
- No Prostate Cancer
- description
- Group drawn of the control group of the case control study, entitled EPICAP
Primary outcomes (1)
- measure
- EORTC Quality of Life Questionnaire - Core 30 Score (EORTC QLQ-C30 Score)
- timeFrame
- 3 years from diagnosis for cases of prostate cancer and from recruitment for controls
Eligibility
Eligibility (as posted)
- Sex
- Male
- Maximum age
- 75 Years
Show eligibility criteria text
\- exposed group Inclusion Criteria: * prostate cancer diagnosed from 1 December 2011 to 31 December 2014 * under 75 and residing in the Hérault department at diagnosis * recruited in the EPICAP study Exclusion criteria: * having relapsed in the range * non-exposed group: Inclusion Criteria: * controls (without prostate cancer) recruited in the EPICAP study * matched to cases on age (5 years) * residing in the Hérault department Exclusion criteria: * diagnosis of prostate cancer set in the range
References
Publications (1)
- RESULTHouede N, Rebillard X, Bouvet S, Kabani S, Fabbro-Peray P, Tretarre B, Menegaux F. Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study. BMC Cancer. 2020 Aug 12;20(1):757. doi: 10.1186/s12885-020-07244-y. PMID 32787797